TrialActa haematologica2026

Impact of Early-Onset or Worsening Anemia in Patients with Myelofibrosis Treated with Ruxolitinib: A post hoc Analysis of the JUMP Study.

Haifa Kathrin Al-Ali et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.